1. Home
  2. TRMK vs TNGX Comparison

TRMK vs TNGX Comparison

Compare TRMK & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$43.85

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$21.76

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
TNGX
Founded
1889
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRMK
TNGX
Price
$43.85
$21.76
Analyst Decision
Hold
Strong Buy
Analyst Count
2
10
Target Price
$44.50
$21.78
AVG Volume (30 Days)
292.2K
2.5M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.26%
N/A
EPS Growth
1.93
26.89
EPS
0.95
N/A
Revenue
N/A
$62,384,000.00
Revenue This Year
$9.82
N/A
Revenue Next Year
$4.86
N/A
P/E Ratio
$45.53
N/A
Revenue Growth
N/A
48.29
52 Week Low
$33.39
$2.96
52 Week High
$45.99
$28.41

Technical Indicators

Market Signals
Indicator
TRMK
TNGX
Relative Strength Index (RSI) 48.47 49.27
Support Level $43.29 $20.05
Resistance Level $45.48 $22.01
Average True Range (ATR) 0.84 1.87
MACD -0.07 -0.01
Stochastic Oscillator 46.61 37.68

Price Performance

Historical Comparison
TRMK
TNGX

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: